Gennex Laboratories Ltd


BSE: 531739 | NSE: NA | ISIN: INE509C01026 
Market Cap: [Rs.Cr.] 19 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Bulk Drugs

 Discuss this stock

Director's Report

DIRECTORS' REPORT

ANNEXURE TO THE DIRECTORS' REPORT

Information under Section 217(l)(e) of the Companies Act, 1956 read with the Companies(Disclosure of Particulars in the report of the Board of Directors) Rules, 1988

Conservation of Energy:

Assessment of individual equipment/utilities energy requirement (Electricity/Steam) hasbeen done and standard benchmarks have been established. Awareness among the staff andplant workers has been created to have a constant monitor on usage of energy and tooptimize throughout and to avoid wastage and unproductive usage of energy.

Pollution Control:

The Company is a member of the Common Effluent Plant of M/s. Pattancheru EnvirotechLimited and M/s. Progressive Effluent Treatment Limited, Bollaram. As per the orders ofSupreme Court, implementation of the pre-treatment of effluent as per the directions ofCentral Pollution Control Board is already under strict implementation.

FORM 'A'

Disclosure of particulars with respect to Conservation of Energy (to the extentapplicable)

2012-2013 2011-2012
A. POWER & FUEL CONSUMPTION
1. ELECTRICITY
a. Purchased Units (KWH in Lacs) 5.59 6.89
Total amount (Rs. In Lacs) 42.00 31.63
Rate/Unit (Rs./KWH) 7.51 4.49
b. Owned Generation
Through Diesel Generator Unit 2.76 1.38
(KWH in Lacs)
Total Amount (Rs. In Lacs) 44.00 20.65
Units per liter of Diesel Oil 3.09 3.02
Cost/Unit (Rs./KWH) 15.94 15.00
2. COAL
Quality 'C' Grade in Steam Boiler
Quantity (Tonnes) 137 247
Total Cost (Rs. in Lacs) 6.64 12.09
Average rate/T (Rs.) 4847 4895
B. CONSUMPTION PER UNIT OF PRODUCTION:
Electricity & Diesel (KWH) 1.72 1.39
Coal (Kgs.) 0.28 0.41

FORM 'B'

2012-2013 2011-2012
RESEARCH & DEVELOPMENT:
1. Specific areas in which R&D Carried out by the Company NIL NIL
2. Benefits derived as a result of the above NIL NIL
3. Future Plan of Action NIL NIL
TECHNOLOGY ABSORBTION, ADAPTATION AND INNOVATION:
1. Effort, in brief, made towards Technology absorption, adaptation and innovation N.A. N.A.
2. Benefits derived as a result of the above efforts N.A. N.A.
3. In case of imported technology (imported during the last 5 years reckoned from the beginning of the financial year), following information may be furnished N.A. N.A.

C. FOREIGN EXCHANGE EARNINGS & OUTGO:

Activities relating to exports, initiative taken to increase exports, developments ofnew export markets for products and services and export plans.

i. The export turnover consists of *35% of total turnover for the year 2012-2013 asagainst *48% for the previous year.

* Direct Exports

ii. Total exports on FOB was Rs.10.15 crores for the year 2012-2013 as against Rs.11.07crores for the year 2011-2012.

iii. Your Company expects considerable export revenue for the forthcoming years

1. Earnings in Foreign Currency on EO.B. basis -
Export of Goods Rs. 101,589,842
2. Value of imports on CLE basis -
- Raw materials Rs. 9,948,564
3. Expenditure in Foreign Currency
a. Bank Charges Rs. 135,468
b. Sales Commission Rs. 2,600,423
c. Travelling Expenses Rs. 301,332
   

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Lupin 50,179.60 21.76 7.19 12.61 39.3 49.4 0.07
Divi's Lab. 19,518.23 24.65 6.43 14.99 25.9 32.9 0.02
Jubilant Life 2,891.30 12.70 1.67 15.32 4.2 7.0 1.52
Shilpa Medicare 1,890.73 23.39 3.88 9.81 14.9 14.9 0.25
Vinati Organics 1,788.20 20.75 5.77 5.75 32.1 27.2 0.96
Marksans Pharma 1,263.78 22.78 8.63 4.97 41.9 19.5 0.00
Suven Life Scie. 1,231.66 8.85 4.66 3.88 68.8 67.7 0.50
Granules India 1,226.46 13.84 3.56 5.09 11.7 13.3 0.76
Dishman Pharma. 1,219.78 14.06 1.53 5.90 9.1 11.6 0.72
Sequent Scien. 1,020.42 0.00 25.39 0.00 0.0 0.0 2.06
Hikal 1,007.53 15.72 2.53 8.61 -2.5 5.0 1.57
Shasun Pharma. 956.57 28.01 2.70 8.58 11.7 9.0 1.56
Aarti Drugs 751.43 12.91 2.99 4.35 26.9 21.9 1.39
Nectar Lifesci. 611.22 9.84 0.66 4.00 10.4 12.8 1.16
Orchid Chemicals 525.56 0.00 1.08 16.79 0.0 0.0 3.31

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

U C Bhandari , Director  

Y Ravinder Reddy , Director  

Arihant Baid , Managing Director &Addtnl Dir.  

Tiruvarur Muralidharan Gopalakrishnan , Addi.Direct. & Whole Time Dire  


Company Head Office / Quarters:
Survey No 133 Bollaram,
Jinnaram Mandal,
Medak,
Andhra Pradesh-502325
Phone : 91-8452-279516/279406
Fax : 91-8452-279516
E-mail :
Web : http://
Registrars:
AMI Computers (I) Ltd
60A & 60B
Chowringhee Road
2nd Floor
Kolkata - 700 0207A Betala Road
1st Floor

Kolkata - 700 026

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

Jul-2014
M T W T F S S
28 29 30 31 01 02 03
IPO
listNo IPO today
Economic Events
list Foreign Buying Japan Bonds (Yen)
list Foreign Buying Japan Stocks (Yen)
Results
list Arvind Ltd | Bharat Forge | CESC | CESC